                               SEQUENCE LISTING

<110> CHILDREN'S MEDICAL CENTER CORPORATION
 
<120> COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING 
      CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

<130> 167705.014001/PCT

<140> PCT/US2018/041043
<141> 2018-07-06

<150> 62/529,256
<151> 2017-07-06

<160> 28    

<170> PatentIn version 3.5

<210> 1
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Lys Lys Ala Leu Arg Arg Gln Glu Ala Val Asp Ala Leu 
1               5                   10              


<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
ttgtaagttt acgtggcagg a                                                 21


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
cgcgtgcata tgtgtgtgta                                                   20


<210> 4
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
acactatgtt tggaaatttg tgcca                                             25


<210> 5
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
tgctttcctg catatatttg gca                                               23


<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
gggctggaga attgaaagaa c                                                 21


<210> 7
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
cccttctaaa ttttgtgact cttca                                             25


<210> 8
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 8
cgtatttctc agacaagcca gg                                                22


<210> 9
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
caaatgatct aggtttctgt gg                                                22


<210> 10
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
gacaaatttg ttaaaataaa gg                                                22


<210> 11
<211> 91
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
cgggagggag acagcatggc cctttacaac cggactcgtc gtattgctca gacaagccag       60

gtaagaattc atcacggtga tgaatcaact g                                      91


<210> 12
<211> 91
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
aggtttttaa tgaggcactg ttttttcaca caaatgatct aggttgctgt ggacgctgcc       60

catggttaca gtccccgggc cattgacatg a                                      91


<210> 13
<211> 91
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 13
attttaggtc atttcccaac aactactggg acaaatttgt taaaataaag gtaatattac       60

ttggaatcct ctacattttt cttaaagcac a                                      91


<210> 14
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Tyr Lys Lys Ala Leu His Arg Gln Glu Ala Val Asp Cys Leu 
1               5                   10                  


<210> 15
<211> 27
<212> DNA
<213> Homo sapiens

<400> 15
aaatttgtta aaagaaaggt aatatta                                           27


<210> 16
<211> 6
<212> PRT
<213> Homo sapiens

<400> 16
Lys Phe Val Lys Arg Lys 
1               5       


<210> 17
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 17
aaatttgtta aaakaaaggt aatatta                                           27


<210> 18
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Lys Phe Val Lys Ala Lys 
1               5       


<210> 19
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 19
aaatttgtta aaataaaggt aatatta                                           27


<210> 20
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Lys Phe Val Lys Ile Lys 
1               5       


<210> 21
<211> 27
<212> DNA
<213> Homo sapiens

<400> 21
actcgtcgta tttctcagac aagccag                                           27


<210> 22
<211> 9
<212> PRT
<213> Homo sapiens

<400> 22
Thr Arg Arg Ile Ser Gln Thr Ser Gln 
1               5                   


<210> 23
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 23
actcgtcgta ttgctcagac aagccag                                           27


<210> 24
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Thr Arg Arg Ile Ala Gln Thr Ser Gln 
1               5                   


<210> 25
<211> 28
<212> DNA
<213> Homo sapiens

<400> 25
aatgatctag gtttctgtgg acgctgcc                                          28


<210> 26
<211> 6
<212> PRT
<213> Homo sapiens

<400> 26
Val Ser Val Asp Ala Ala 
1               5       


<210> 27
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 27
aatgatctag gttgctgtgg acgctgcc                                          28


<210> 28
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Val Ala Val Asp Ala Ala 
1               5       


